Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 3
2004 3
2006 1
2008 5
2009 1
2010 1
2011 1
2018 1
2019 2
2020 1
2021 1
2022 1
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

23 results

Results by year

Filters applied: . Clear all
Page 1
FLT3 inhibitors upregulate CXCR4 and E-selectin ligands via ERK suppression in AML cells and CXCR4/E-selectin inhibition enhances anti-leukemia efficacy of FLT3-targeted therapy in AML.
Jia Y, Zhang W, Basyal M, Chang KH, Ostermann L, Burks JK, Ly C, Mu-Mosley H, Zhang Q, Han X, Fogler WE, Magnani JL, Lesegretain A, Zal AA, Zal T, Andreeff M. Jia Y, et al. Among authors: fogler we. Leukemia. 2023 Jun;37(6):1379-1383. doi: 10.1038/s41375-023-01897-x. Epub 2023 Apr 21. Leukemia. 2023. PMID: 37085610 Free PMC article. No abstract available.
E-selectin inhibitor is superior to low-molecular-weight heparin for the treatment of experimental venous thrombosis.
Myers DD Jr, Ning J, Lester P, Adili R, Hawley A, Durham L, Dunivant V, Reynolds G, Crego K, Sood S, Sigler R, Fogler WE, Magnani JL, Holinstat M, Wakefield T. Myers DD Jr, et al. Among authors: fogler we. J Vasc Surg Venous Lymphat Disord. 2022 Jan;10(1):211-220. doi: 10.1016/j.jvsv.2020.12.086. Epub 2021 Apr 17. J Vasc Surg Venous Lymphat Disord. 2022. PMID: 33872819
A new way to treat proximal deep venous thrombosis using E-selectin inhibition.
Myers D Jr, Lester P, Adili R, Hawley A, Durham L, Dunivant V, Reynolds G, Crego K, Zimmerman Z, Sood S, Sigler R, Fogler W, Magnani J, Holinstat M, Wakefield T. Myers D Jr, et al. Among authors: fogler w. J Vasc Surg Venous Lymphat Disord. 2020 Mar;8(2):268-278. doi: 10.1016/j.jvsv.2019.08.016. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 32067728 Free PMC article.
Assessment of antiangiogenic effect using 99mTc-EC-endostatin.
Yang DJ, Kim KD, Schechter NR, Yu DF, Wu P, Azhdarinia A, Roach JS, Kalimi SK, Ozaki K, Fogler WE, Bryant JL, Herbst R, Abbruzzes J, Kim EE, Podoloff DA. Yang DJ, et al. Among authors: fogler we. Cancer Biother Radiopharm. 2002 Apr;17(2):233-45. doi: 10.1089/108497802753773856. Cancer Biother Radiopharm. 2002. PMID: 12030117
P- and E-selectin receptor antagonism prevents human leukocyte adhesion to activated porcine endothelial monolayers and attenuates porcine endothelial damage.
Laird CT, Hassanein W, O'Neill NA, French BM, Cheng X, Fogler WE, Magnani JL, Parsell D, Cimeno A, Phelps CJ, Ayares D, Burdorf L, Azimzadeh AM, Pierson RN 3rd. Laird CT, et al. Among authors: fogler we. Xenotransplantation. 2018 Mar;25(2):e12381. doi: 10.1111/xen.12381. Epub 2018 Jan 23. Xenotransplantation. 2018. PMID: 29359469 Free PMC article.
23 results